Arkolith/Insider Trading/REPL/Form 4

Xynos Konstantinos

Chief Medical OfficerReplimune Group, Inc. (REPL) · full profile →Form 4 · filed May 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Sell(S)8K$8.06$64K147K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-052145) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML